Bantam Pharmaceutical Revenue and Competitors
Estimated Revenue & Valuation
- Bantam Pharmaceutical's estimated annual revenue is currently $703.5k per year.
- Bantam Pharmaceutical's estimated revenue per employee is $100,500
- Bantam Pharmaceutical's total funding is $25M.
Employee Data
- Bantam Pharmaceutical has 7 Employees.
- Bantam Pharmaceutical grew their employee count by 0% last year.
Bantam Pharmaceutical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Chemistry | Reveal Email/Phone |
2 | Head CMC | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | President and CEO | Reveal Email/Phone |
Bantam Pharmaceutical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.8M | 29 | 4% | N/A | N/A |
#2 | $3.2M | 16 | 0% | N/A | N/A |
#3 | $83.2M | 414 | 7% | N/A | N/A |
#4 | $31M | 154 | 56% | N/A | N/A |
#5 | $66.6M | 265 | 0% | $35M | N/A |
#6 | $10.9M | 54 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -6% | N/A | N/A |
#8 | $165.7M | 216 | 14% | $250.7M | N/A |
#9 | $26.5M | 132 | -11% | $637.8K | N/A |
#10 | $49.4M | 246 | 6% | N/A | N/A |
What Is Bantam Pharmaceutical?
Bantam Pharmaceutical is a drug discovery company harnessing the power of mitochondrial dynamics to address unmet needs in oncology. Using its unique expertise in mitochondrial dynamics, Bantam is developing novel, first-in-class small molecule oral therapeutics for difficult-to-treat hematological and solid tumors. Bantam is currently pursuing an IND application for Its lead candidate, BTM-3566, in B-cell malignancies. About BTM-3566 BTM-3566 is an orally-available novel small molecule compound with broad anti-cancer activity in hematologic and solid tumors, initially focused on Diffuse Large B-cell Lymphomas (DLBCL). BTM-3566’s anti-cancer mechanism of action is unique from any other therapeutic, disrupting mitochondrial function in tumor cells to induce apoptosis (cell death). An IND application for BTM-3566 in B-cell malignancies is currently underway and will be completed by Q1 2022.
keywords:N/A
$25M
Total Funding
7
Number of Employees
$703.5k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bantam Pharmaceutical News
Bantam Pharmaceutical is a drug discovery and development company channeling the power of mitochondrial dynamics to address unmet needs in...
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 7 | 0% | N/A |
#2 | $0.5M | 7 | -36% | N/A |
#3 | $1.1M | 7 | 0% | N/A |
#4 | $0.5M | 7 | -12% | N/A |
#5 | $0.5M | 7 | -30% | N/A |